Angiotensin II signaling in vascular smooth muscle cells under high glucose conditions

Hypertension

Volumn 33, Issue 1 II, 1999, Pages 378-384

  Natarajan, Rama ^a   Scott, Stephen ^a   Wei, Bai ^a   Yerneni, Kiran Kumar V ^a   Nadler, Jerry ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Activator protein 1; Angiotensin II; Diabetes mellitus; Hyperglycemia; Mitogen activated protein kinases; Muscle, smooth, vascular

Indexed keywords

ANGIOTENSIN; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; DIABETES MELLITUS; DNA BINDING; DRUG EFFECT; ENZYME ACTIVATION; ENZYME REGULATION; GLUCOSE METABOLISM; HYPERGLYCEMIA; MULTIGENE FAMILY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SWINE; VASCULAR SMOOTH MUSCLE;

EID: 0032921741     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.33.1.378     Document Type: Article

References (26)

1. Natarajan R, Gonzales N, Xu L, Nadler J. Vascular smooth muscle cells exhibit increased growth response to elevated glucose. Biochem Biophys Res Commun. 1992;87:552-560.
2. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J. 1995;9: 726-735.
3. Force T, Bonventre JV. Growth factors and mitogen-activated protein kinases. Hypertension. 1998;31(pt 2):152-161.
4. Davis RJ. MAPKs: new JNK expands the group. Trends Biochem Sci. 1994;19:470-473.
5. Natarajan R, Gonzales N, Lanting L, Nadler J. Role of the lipoxygenase pathway in angiotensin II induced vascular smooth muscle cell hypertrophy. Hypertension. 1994;23(suppl I):I-142-I-147.
6. Kyriakis JM, Woodgett JR, Avruch J. The stress-activated protein kinases. Ann NY Acad Sci. 1995;766:303-319.
7. Abe J-I, Kusuhara M, Ulevitch RJ, Berk BC, Lee J-D. Big MAP kinase 1 (BMK1) is a redox sensitive kinase. J Biol Chem. 1996;271: 16586-16590.
8. 2-terminal kinase in ventricular muscle cells. J Biol Chem. 1998;273:5423-5426.
9. Wang Y, Huang S, Shah VP, Ross J Jr, Brown JH, Han J, Chien KR. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem. 1998;273:2161-2168.
10. Ushi-Fukai M, Alexander RW, Akers M, Griendling KK. p38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. J Biol Chem. 1998;273: 15022-15029.
11. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Derijard B, Davis RJ. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 1996;15:2760-2770.
12. Raingeaud J, Gupta S, Rogers JS, Dickens, Han J, Ulevitch RJ, Davis RJ. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem. 1995;270:7420-7426.
13. Tan Y, Rouse J, Zhang A, Cariati S, Cohen P, Comb MJ. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J. 1996;15:4629-4642.
14. Duff JL, Berk BC, Corson MA. Angiotensin II stimulates the pp44 and pp42 MAPKs in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun. 1992;188:257-264.
15. Schmitz U, Ishida T, Ishida M, Surapisitchat J, Hasham MI, Pelech S, Berk BC. Angiotensin H stimulates p21-activated kinase in vascular smooth muscle cells: role of activation of JNK. Circ Res. 1998;82: 1272-1278.
16. 2-terminal kinase. Circ Res. 1997;81:651-655.
17. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem. 1995;270:16483-16486.
18. Whitmarsh AJ, Davis RJ. Transcription factor AP-1 regulation by mitogen-activaled protein kinase signal transduction pathways. J Mol Med. 1996;74:589-607.
19. Takeuchi K, Nakamura N, Cook NS, Pratt RE, Dzau VJ. Angiotensin II can regulate gene expression by the AP-1 binding sequence via a protein kinase C-dependent pathway. Biochem Biophys Res Commun. 1990;172: 1189-1194.
20. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human endothelial cells. J Clin Invest. 1993;92:1866-1874.
21. Wen Y, Nadler JL, Gonzales N, Scott S, Clauser E, Natarajan R. Mechanisms of ANG II-induced mitogenic responses: role of 12-lipoxygenase and biphasic MAP kinase. Am J Physiol. 1996;271(Cell Physiol 40): C1212-C1220.
22. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
23. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes. 1998;47:859-866.
24. Berk BC, Duff JL, Marrero MB, Bernstein KE. Angiotensin II signal transduction in vascular smooth muscle. In Sowers JR, ed. Contemporary Endocrinology: Endocrinology of the Vasculature. Totowa, NJ: Humana Press; 1996:187-204.
25. Natarajan R, Gu JL, Rossi JJ, Gonzales N, Lanting L, Xu L, Nadler J. Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells. Proc Natl Acad Sci USA. 1993;90:4947-4951.
26. Rao GN, Glasgow WC, Eling TE, Runge MS. Role of hydroperoxyeico-satetraenoic acids in oxidative stress-inducing activating protein 1 (AP-1) activity. J Biol Chem. 1996;271:27760-27764.